Rockwell Medical, Inc.เพิ่มขึ้น
Rockwell Medical RMTI
This is a turn around story.
New management changed the direction of how they did things and 2nd quarter earnings just released was recognition that they are on the right path.
The chart tells the whole story and head and shoulder bottom and break out. Rockwell is a microcap manufacturer of hemodialysis concentrates for kidney failure patients, trading at under 1x full-year 2023 revenue. A company where there is no reason demand will not continue regardless of the economy.
Several wall street analysis predict this is $9 dollar stock. But it is hard to argue that this stock will double in price from this point.
New management changed the direction of how they did things and 2nd quarter earnings just released was recognition that they are on the right path.
The chart tells the whole story and head and shoulder bottom and break out. Rockwell is a microcap manufacturer of hemodialysis concentrates for kidney failure patients, trading at under 1x full-year 2023 revenue. A company where there is no reason demand will not continue regardless of the economy.
Several wall street analysis predict this is $9 dollar stock. But it is hard to argue that this stock will double in price from this point.
คำจำกัดสิทธิ์ความรับผิดชอบ
ข้อมูลและบทความไม่ได้มีวัตถุประสงค์เพื่อก่อให้เกิดกิจกรรมทางการเงิน, การลงทุน, การซื้อขาย, ข้อเสนอแนะ หรือคำแนะนำประเภทอื่น ๆ ที่ให้หรือรับรองโดย TradingView อ่านเพิ่มเติมที่ ข้อกำหนดการใช้งาน